ARTICLE | Company News
Yamanouchi, Medtronic licensing deal
August 21, 2003 7:00 AM UTC
Yamanouchi (Tokyo, Japan) granted MDT exclusive commercialization rights to its implantable recombinant human bone morphogenic protein (rhBMP-2) for use in orthopedic surgery in Asia. MDT's Japanese s...